Biogen (BIIB) weekly IV elevated into EPS and new product timeline outlook

Biogen (NASDAQ: BIIB) April weekly call option implied volatility is at 112, May is at 62; compared to its 52-week range of 25 to 63 into the expected release of quarter results before the bell on April 22.

You May Also Be Interested In

• Roundhill T-Rex 2X Long Dram Daily (RAM) call put ratio 1.8 calls to 1 put on 17K contracts
• JPMorgan (JPM) call put ratio 2.2 calls to 1 put into quarter results
• AstraZeneca (AZN) call put ratio 1.9 calls to 1 put with a focus on July 180 and 190 calls